Pages with the most revisions

Jump to navigation Jump to search

Showing below up to 250 results in range #51 to #300.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. Fibroblastic/myofibroblastic tumours‏‎ (143 revisions)
  2. Lymphoma‏‎ (140 revisions)
  3. Liver pathology‏‎ (138 revisions)
  4. Colorectal tumours‏‎ (135 revisions)
  5. Malignant melanoma‏‎ (135 revisions)
  6. Peripheral nerve sheath tumours‏‎ (133 revisions)
  7. Vulva‏‎ (132 revisions)
  8. Gallbladder‏‎ (130 revisions)
  9. Heart valves‏‎ (127 revisions)
  10. Gestational trophoblastic disease‏‎ (125 revisions)
  11. Germ cell tumours‏‎ (119 revisions)
  12. Heart‏‎ (116 revisions)
  13. Vermiform appendix‏‎ (113 revisions)
  14. Bone‏‎ (112 revisions)
  15. Dermal cysts‏‎ (112 revisions)
  16. Microorganisms‏‎ (108 revisions)
  17. Vasculitides‏‎ (108 revisions)
  18. Endometrial carcinoma‏‎ (108 revisions)
  19. Small intestine‏‎ (103 revisions)
  20. Meningioma‏‎ (102 revisions)
  21. Adipocytic tumours‏‎ (102 revisions)
  22. Small cell lymphomas‏‎ (101 revisions)
  23. Pathology links‏‎ (100 revisions)
  24. Cases‏‎ (100 revisions)
  25. Vascular disease‏‎ (97 revisions)
  26. Amyloid‏‎ (95 revisions)
  27. Adenocarcinoma of the lung‏‎ (93 revisions)
  28. Diffuse lung diseases‏‎ (91 revisions)
  29. Pituitary gland‏‎ (91 revisions)
  30. Vascular tumours‏‎ (90 revisions)
  31. An introduction to gynecologic pathology‏‎ (89 revisions)
  32. Pulmonary cytopathology‏‎ (89 revisions)
  33. Short power list‏‎ (88 revisions)
  34. Non-invasive breast carcinoma‏‎ (87 revisions)
  35. Fungi‏‎ (86 revisions)
  36. Urothelial carcinoma‏‎ (85 revisions)
  37. Celiac sprue‏‎ (83 revisions)
  38. Neurohistology‏‎ (82 revisions)
  39. Parathyroid glands‏‎ (82 revisions)
  40. Cytopathology‏‎ (79 revisions)
  41. Spleen‏‎ (79 revisions)
  42. Pulmonary pathology‏‎ (78 revisions)
  43. Surgical margins‏‎ (75 revisions)
  44. Thyroid cytopathology‏‎ (74 revisions)
  45. Quality‏‎ (71 revisions)
  46. Mesothelial cytopathology‏‎ (70 revisions)
  47. Pediatric gastrointestinal pathology‏‎ (70 revisions)
  48. Colorectal adenocarcinoma‏‎ (70 revisions)
  49. MEDITECH‏‎ (70 revisions)
  50. Viruses‏‎ (70 revisions)
  51. Libre Pathology‏‎ (69 revisions)
  52. Products of conception‏‎ (68 revisions)
  53. Papillary renal cell carcinoma‏‎ (67 revisions)
  54. Bacteria‏‎ (67 revisions)
  55. Haematopathology‏‎ (67 revisions)
  56. Uterine tubes‏‎ (66 revisions)
  57. Endometrial hyperplasia‏‎ (66 revisions)
  58. Asphyxial deaths‏‎ (66 revisions)
  59. Traditional adenoma‏‎ (65 revisions)
  60. Spot diagnoses‏‎ (65 revisions)
  61. Gross pathology‏‎ (65 revisions)
  62. Penis‏‎ (65 revisions)
  63. Molecular pathology‏‎ (62 revisions)
  64. Thymus‏‎ (62 revisions)
  65. Gastrointestinal stromal tumour‏‎ (62 revisions)
  66. Anus‏‎ (62 revisions)
  67. Uterus‏‎ (62 revisions)
  68. Oral pathology‏‎ (62 revisions)
  69. Squamous cell carcinoma‏‎ (61 revisions)
  70. Clear cell renal cell carcinoma‏‎ (61 revisions)
  71. Bullous diseases‏‎ (61 revisions)
  72. Extramammary Paget disease‏‎ (60 revisions)
  73. Femoral head‏‎ (60 revisions)
  74. Hodgkin lymphoma‏‎ (60 revisions)
  75. Chondrosarcoma‏‎ (59 revisions)
  76. Small round cell tumours‏‎ (59 revisions)
  77. Rheumatoid arthritis‏‎ (59 revisions)
  78. Odontogenic tumours and cysts‏‎ (58 revisions)
  79. Pediatric pathology‏‎ (58 revisions)
  80. Vas deferens‏‎ (58 revisions)
  81. Hereditary leiomyomatosis and renal cell carcinoma syndrome‏‎ (57 revisions)
  82. LP:Sandbox‏‎ (57 revisions)
  83. Head and neck cytopathology‏‎ (57 revisions)
  84. Succinate dehydrogenase-deficient renal cell carcinoma‏‎ (56 revisions)
  85. Angiomyolipoma‏‎ (55 revisions)
  86. Cardiac tumours‏‎ (55 revisions)
  87. Endometriosis‏‎ (54 revisions)
  88. Spindle cell lesions‏‎ (54 revisions)
  89. Diffuse large B-cell lymphoma‏‎ (54 revisions)
  90. Metastases‏‎ (54 revisions)
  91. Sertoli-Leydig cell tumour‏‎ (54 revisions)
  92. An introduction to gastrointestinal pathology‏‎ (54 revisions)
  93. Non-small cell lung carcinoma‏‎ (53 revisions)
  94. Clinical history‏‎ (53 revisions)
  95. Trophoblast‏‎ (53 revisions)
  96. Intracranial hematomas‏‎ (52 revisions)
  97. Prostate cancer grading‏‎ (52 revisions)
  98. Urinary bladder‏‎ (52 revisions)
  99. Crystals in body fluids‏‎ (51 revisions)
  100. Clear cell papillary renal cell tumour‏‎ (51 revisions)
  101. Osteoarthritis‏‎ (50 revisions)
  102. Renal oncocytoma‏‎ (50 revisions)
  103. Gastrointestinal cytopathology‏‎ (50 revisions)
  104. Intraoperative consultation‏‎ (50 revisions)
  105. Ampulla of Vater‏‎ (49 revisions)
  106. Tuberous sclerosis‏‎ (49 revisions)
  107. Malignant mesothelioma‏‎ (49 revisions)
  108. Pheochromocytoma‏‎ (48 revisions)
  109. Neuroendocrine neoplasms‏‎ (48 revisions)
  110. TFE3-rearranged renal cell carcinoma‏‎ (47 revisions)
  111. Congenital heart disease‏‎ (47 revisions)
  112. L4E rule 1-3 (2014)‏‎ (47 revisions)
  113. Chromophobe renal cell carcinoma‏‎ (47 revisions)
  114. Granular cell tumour‏‎ (46 revisions)
  115. Rhabdomyosarcoma‏‎ (45 revisions)
  116. Hypertension‏‎ (45 revisions)
  117. Astrocytoma‏‎ (45 revisions)
  118. Pulmonary embolism‏‎ (45 revisions)
  119. Urine cytopathology‏‎ (45 revisions)
  120. Gunshot wounds‏‎ (45 revisions)
  121. Desmoid-type fibromatosis‏‎ (44 revisions)
  122. Chromosomal translocations‏‎ (44 revisions)
  123. TFEB-rearranged renal cell carcinoma‏‎ (44 revisions)
  124. Breast cytopathology‏‎ (44 revisions)
  125. Craniopharyngioma‏‎ (43 revisions)
  126. Diverticular disease‏‎ (43 revisions)
  127. Joints‏‎ (43 revisions)
  128. Familial adenomatous polyposis‏‎ (43 revisions)
  129. Level 4 equivalent of 2014‏‎ (42 revisions)
  130. Renal mucinous tubular and spindle cell carcinoma‏‎ (42 revisions)
  131. Seminoma‏‎ (42 revisions)
  132. Mucinous carcinoma‏‎ (42 revisions)
  133. ELOC-mutated renal cell carcinoma‏‎ (42 revisions)
  134. Sarcoidosis‏‎ (42 revisions)
  135. Basal cell carcinoma‏‎ (42 revisions)
  136. OP:Sandbox3‏‎ (42 revisions)
  137. SMARCB1-deficient renal medullary carcinoma‏‎ (42 revisions)
  138. Secretory carcinoma of the salivary gland‏‎ (42 revisions)
  139. Small cell carcinoma‏‎ (41 revisions)
  140. Renal tumours with eosinophilic cytoplasm‏‎ (41 revisions)
  141. Leiomyoma‏‎ (41 revisions)
  142. Ependymoma‏‎ (41 revisions)
  143. Lymph node metastasis‏‎ (41 revisions)
  144. Sjögren syndrome‏‎ (40 revisions)
  145. Signet ring cell carcinoma‏‎ (40 revisions)
  146. Nephrogenic adenoma‏‎ (40 revisions)
  147. Informatics‏‎ (40 revisions)
  148. Programmed death-ligand 1‏‎ (39 revisions)
  149. Hyperplastic polyp‏‎ (39 revisions)
  150. P16‏‎ (39 revisions)
  151. Cystic kidney diseases‏‎ (39 revisions)
  152. Giant cell arteritis‏‎ (39 revisions)
  153. Leukemia‏‎ (38 revisions)
  154. Robbins and Cotran 9th Edition Questions‏‎ (38 revisions)
  155. Papillary thyroid carcinoma‏‎ (38 revisions)
  156. Nephrotic syndrome‏‎ (38 revisions)
  157. Lymphovascular invasion‏‎ (38 revisions)
  158. Seborrheic keratosis‏‎ (38 revisions)
  159. Acquired cystic disease-associated renal cell carcinoma‏‎ (38 revisions)
  160. Schwannoma‏‎ (37 revisions)
  161. Glomus tumour‏‎ (37 revisions)
  162. Cardiomyopathy‏‎ (37 revisions)
  163. Metaphyseal fibrous defect‏‎ (37 revisions)
  164. Neurofibromatosis‏‎ (37 revisions)
  165. Pneumonia‏‎ (36 revisions)
  166. Total nephrectomy for tumour grossing‏‎ (36 revisions)
  167. Serous carcinoma of the ovary‏‎ (36 revisions)
  168. NUT carcinoma‏‎ (36 revisions)
  169. Renal angiomyoadenomatous tumour‏‎ (35 revisions)
  170. Prostate-specific antigen‏‎ (35 revisions)
  171. Lymph nodes‏‎ (35 revisions)
  172. Helicobacter gastritis‏‎ (35 revisions)
  173. Renal transplant pathology‏‎ (34 revisions)
  174. Heart transplant pathology‏‎ (34 revisions)
  175. Medullary thyroid carcinoma‏‎ (34 revisions)
  176. Cancer staging systems‏‎ (34 revisions)
  177. Thrombotic microangiopathy‏‎ (34 revisions)
  178. Low-grade oncocytic renal tumour‏‎ (34 revisions)
  179. Steatohepatitis‏‎ (34 revisions)
  180. GATA3‏‎ (34 revisions)
  181. Multiple endocrine neoplasia‏‎ (33 revisions)
  182. Pulmonary alveolar proteinosis‏‎ (33 revisions)
  183. Typical carcinoid lung tumour‏‎ (33 revisions)
  184. Sessile serrated adenoma‏‎ (33 revisions)
  185. Langerhans cell histiocytosis‏‎ (33 revisions)
  186. Squamous cell carcinoma of the lung‏‎ (33 revisions)
  187. Acinic cell carcinoma‏‎ (33 revisions)
  188. Twin placentas‏‎ (33 revisions)
  189. Cervical polyps‏‎ (33 revisions)
  190. Intraductal carcinoma of the prostate‏‎ (33 revisions)
  191. Squamous cell carcinoma of the head and neck‏‎ (33 revisions)
  192. Fibromatoses‏‎ (33 revisions)
  193. Gastritis‏‎ (33 revisions)
  194. Urothelial dysplasia‏‎ (32 revisions)
  195. Principles of gross pathology‏‎ (32 revisions)
  196. Ovary‏‎ (32 revisions)
  197. Fetal autopsy‏‎ (32 revisions)
  198. Glioblastoma‏‎ (32 revisions)
  199. Esophageal adenocarcinoma‏‎ (32 revisions)
  200. Intranodal palisaded myofibroblastoma‏‎ (32 revisions)
  201. Yolk sac tumour‏‎ (32 revisions)
  202. Oligodendroglioma‏‎ (31 revisions)
  203. Lung cancer staging‏‎ (31 revisions)
  204. Paraganglioma‏‎ (31 revisions)
  205. Nasopharyngeal carcinoma‏‎ (31 revisions)
  206. Radiation changes‏‎ (31 revisions)
  207. Plasma cell neoplasms‏‎ (31 revisions)
  208. Granuloma‏‎ (31 revisions)
  209. Microphotography‏‎ (31 revisions)
  210. Adenocarcinoma of the urinary bladder‏‎ (31 revisions)
  211. Sarcoma with CIC-rearrangement‏‎ (31 revisions)
  212. Small cell carcinoma of the lung‏‎ (31 revisions)
  213. Critical values‏‎ (31 revisions)
  214. Lynch syndrome‏‎ (31 revisions)
  215. Chordoma‏‎ (31 revisions)
  216. Pleomorphic adenoma‏‎ (30 revisions)
  217. Pineal gland‏‎ (30 revisions)
  218. Leiomyosarcoma‏‎ (30 revisions)
  219. Breast grossing‏‎ (30 revisions)
  220. Pathology reports‏‎ (30 revisions)
  221. Cartilage‏‎ (30 revisions)
  222. Micropapillary urothelial carcinoma‏‎ (30 revisions)
  223. Colorectal cancer staging‏‎ (30 revisions)
  224. Orchiectomy grossing‏‎ (30 revisions)
  225. Pediatric kidney tumours‏‎ (30 revisions)
  226. Cytogenetics Review Questions‏‎ (30 revisions)
  227. Programmed cell death 1‏‎ (30 revisions)
  228. Urachal carcinoma‏‎ (30 revisions)
  229. ALK translocation renal cell carcinoma‏‎ (29 revisions)
  230. Multilocular cystic renal neoplasm of low malignant potential‏‎ (29 revisions)
  231. Adenoid cystic carcinoma‏‎ (29 revisions)
  232. Mucoepidermoid carcinoma‏‎ (29 revisions)
  233. Cystic tumour of the atrioventricular nodal region‏‎ (29 revisions)
  234. Hemophagocytic syndrome‏‎ (29 revisions)
  235. Lung carcinoma with ALK rearrangement‏‎ (29 revisions)
  236. Teratoma‏‎ (29 revisions)
  237. Tubulocystic carcinoma of the kidney‏‎ (29 revisions)
  238. CSF cytopathology‏‎ (28 revisions)
  239. Waffle diagnosis‏‎ (28 revisions)
  240. Libre Pathology news‏‎ (28 revisions)
  241. Vagina‏‎ (28 revisions)
  242. TRK fusions‏‎ (28 revisions)
  243. Wilms tumour‏‎ (28 revisions)
  244. Peritoneum‏‎ (28 revisions)
  245. Urothelial carcinoma in situ‏‎ (28 revisions)
  246. Squamous cell carcinoma of the skin‏‎ (28 revisions)
  247. Embryonal carcinoma‏‎ (28 revisions)
  248. Quiz:L4E uropathology (2014)‏‎ (28 revisions)
  249. Warthin tumour‏‎ (28 revisions)
  250. Acute appendicitis‏‎ (28 revisions)

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)